These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 38060107)

  • 1. Calcinosis in Juvenile Dermatomyositis-Epidemiology, Pathogenesis, Clinical Features, and Treatment: A Systematic Review.
    Gonçalves Júnior J; Shinjo SK
    Curr Rheumatol Rep; 2024 Feb; 26(2):53-68. PubMed ID: 38060107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical profile of anti-NXP-2 antibody-positive inflammatory myositis and outcome in an Indian population.
    Manwatkar A; Padiyar S; Nair A; Jha A; Kumar S; Yadav B; Prakash JAJ; Das JK; Mathew J
    Clin Rheumatol; 2023 Dec; 42(12):3289-3297. PubMed ID: 37801141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Juvenile Dermatomyositis: Advances in Pathogenesis, Assessment, and Management.
    Leung AKC; Lam JM; Alobaida S; Leong KF; Wong AHC
    Curr Pediatr Rev; 2021; 17(4):273-287. PubMed ID: 33902423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis.
    Gunawardena H; Wedderburn LR; Chinoy H; Betteridge ZE; North J; Ollier WE; Cooper RG; Oddis CV; Ramanan AV; Davidson JE; McHugh NJ;
    Arthritis Rheum; 2009 Jun; 60(6):1807-14. PubMed ID: 19479859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Juvenile dermatomyositis associated with autoantibodies to small ubiquitin-like modifier activating enzyme: a report of 4 cases from North India and a review of literature.
    Vignesh P; Barman P; Basu S; Mondal S; Ishran B; Kumrah R; Dod A; Garg R; Rawat A; Singh S
    Immunol Res; 2023 Feb; 71(1):112-120. PubMed ID: 36278969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset.
    Tansley SL; Betteridge ZE; Shaddick G; Gunawardena H; Arnold K; Wedderburn LR; McHugh NJ;
    Rheumatology (Oxford); 2014 Dec; 53(12):2204-8. PubMed ID: 24987158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcinosis Biomarkers in Adult and Juvenile Dermatomyositis.
    Chung MP; Richardson C; Kirakossian D; Orandi AB; Saketkoo LA; Rider LG; Schiffenbauer A; von Mühlen CA; Chung L; ;
    Autoimmun Rev; 2020 Jun; 19(6):102533. PubMed ID: 32234404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinuclear Matrix Protein 2 Autoantibodies and Edema, Muscle Disease, and Malignancy Risk in Dermatomyositis Patients.
    Albayda J; Pinal-Fernandez I; Huang W; Parks C; Paik J; Casciola-Rosen L; Danoff SK; Johnson C; Christopher-Stine L; Mammen AL
    Arthritis Care Res (Hoboken); 2017 Nov; 69(11):1771-1776. PubMed ID: 28085235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibody Profile of Children with Juvenile Dermatomyositis.
    Sharma A; Bhattarai D; Gupta A; Guleria S; Rawat A; Vignesh P; Garg R; Singh S
    Indian J Pediatr; 2021 Dec; 88(12):1170-1173. PubMed ID: 33694062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory myopathies overlapping with systemic sclerosis: a systematic review.
    Júnior JG; Mugii N; Inaoka PT; Sampaio-Barros PD; Shinjo SK
    Clin Rheumatol; 2022 Jul; 41(7):1951-1963. PubMed ID: 35220464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.
    Rider LG; Shah M; Mamyrova G; Huber AM; Rice MM; Targoff IN; Miller FW;
    Medicine (Baltimore); 2013 Jul; 92(4):223-243. PubMed ID: 23877355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent research on myositis-specific autoantibodies in juvenile dermatomyositis.
    He L
    Zhongguo Dang Dai Er Ke Za Zhi; 2021 Oct; 23(10):1064-1068. PubMed ID: 34719424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and prognostic factor in juvenile dermatomyositis: data of the Spanish registry.
    Carriquí-Arenas S; Mosquera JM; Quesada-Masachs E; López M; Clemente D; Boteanu A; Udaondo C; de Inocencio J; Nieto JC; Riancho L; Núñez E; Sánchez-Manubens J; Lirola MJ; Roldán R; Camacho M; Martínez M; Medrano M; Alcañiz P; Antón J; Iglesias E
    Pediatr Rheumatol Online J; 2024 Jul; 22(1):66. PubMed ID: 39039532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Juvenile dermatomyositis with Anti-SAE antibodies in a Moroccan child associated with pseudo-angioedema: a case report.
    Nainia K; Aouzal MA; Ouafik I; Charhbili M; Bouchhab A; Daoudi A; Tizki S; Chakiri R
    Pediatr Rheumatol Online J; 2024 May; 22(1):57. PubMed ID: 38773611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcinosis in juvenile dermatomyositis: frequency, risk factors and outcome.
    Saini I; Kalaivani M; Kabra SK
    Rheumatol Int; 2016 Jul; 36(7):961-5. PubMed ID: 27007612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Calcinosis in Juvenile Dermatomyositis.
    Kul Cinar O; Papadopoulou C; Pilkington CA
    Curr Rheumatol Rep; 2021 Feb; 23(2):13. PubMed ID: 33555459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Juvenile dermatomyositis in Thai children: Retrospective review of 30 cases from a tertiary care center.
    Nitiyarom R; Charuvanij S; Likasitwattanakul S; Thanoophunchai C; Wisuthsarewong W
    Indian J Dermatol Venereol Leprol; 2022; 88(2):162-170. PubMed ID: 34491668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical features of juvenile dermatomyositis: A single-centre inception cohort.
    Cancarini P; Nozawa T; Whitney K; Bell-Peter A; Marcuz JA; Taddio A; Guo J; Dover S; Feldman BM
    Semin Arthritis Rheum; 2022 Dec; 57():152104. PubMed ID: 36183479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Juvenile-onset clinically amyopathic dermatomyositis: an overview of recent progress in diagnosis and management.
    Walling HW; Gerami P; Sontheimer RD
    Paediatr Drugs; 2010; 12(1):23-34. PubMed ID: 20034339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.